In patients with type 2 diabetes on metformin, the addition of which antihyperglycemic class among a sulfonylurea (glimepiride), a DPP-4 inhibitor (sitagliptin), a GLP-1 agonist (liraglutide), or basal insulin (glargine) is the most effective to achieve and maintain good glycemic control?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	La revue de medecine interne 2023-01, Vol.44 (1), p.48-49
Hauptverfasser:	Lanthier, L, Mutchmore, A, Plourde, M-É, Cauchon, M
Format:	Artikel
Sprache:	fre
Schlagworte:	Blood Glucose Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Drug Therapy, Combination Glucagon-Like Peptide 1 - therapeutic use Glycemic Control Humans Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Insulin Glargine - therapeutic use Liraglutide - therapeutic use Metformin - pharmacology Metformin - therapeutic use Sitagliptin Phosphate - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!